Skybiotech Healthcare chairman and AGM
BSE: 512036Textiles & ApparelsSmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹116.00.
28 Oct: open ₹116.00, high ₹116.00, low ₹116.00
- Under BSE's graded surveillance, stage 0, on the list for 26 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr3,866th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.91
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1
Skybiotech Healthcare's chairperson is PRAKASHCHANDRA RATHI, as filed for the quarter to Dec 2024. Its latest annual general meeting was on 30 Sep 2026.
Skybiotech Healthcare board of directors
At the end of the quarter to Dec 2024, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonPRAKASHCHANDRA RATHIRelated to the promoter
6 directors2 independent4 executive
- PRAKASHCHANDRA RATHI · ChairpersonExecutive · joined Jun 2003 · reappointed Jun 2003 · 1 listed board
- POONAM PRAKASH RATHIExecutive · joined Feb 2005 · reappointed Feb 2005 · 1 listed board · 3 committee seats
- YOGESH NANDLAL CHANDAKExecutive · joined Feb 2005 · reappointed Feb 2005 · 1 listed board
- RAKESH RAMSWAROOP SOMANIIndependent · joined Sep 2017 · reappointed Sep 2022 · 60 months as independent · 1 listed board · 1 as independent · 3 committee seats, 3 as chair
- JAGDISH MANOHAR MANTRIIndependent · joined Sep 2017 · reappointed Sep 2022 · 60 months as independent · 1 listed board · 1 as independent · 3 committee seats
- SANTOSH SHIVAJI PIMPARKARExecutive · joined Nov 2024 · reappointed Nov 2024 · 2 listed boards
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 14 Nov 20245 of 5 present2 independent · 45 days in between
- 29 Sep 20245 of 5 present2 independent · 45 days in between
- 14 Aug 20244 of 5 present2 independent
Audit Committee
Chair RAKESH RAMSWAROOP SOMANI
JAGDISH MANOHAR MANTRI, POONAM PRAKASH RATHI
- 14 Nov 20243 of 3 present2 independent · 91 days in between
- 14 Aug 20243 of 3 present2 independent
Nomination and remuneration committee
Chair RAKESH RAMSWAROOP SOMANI
JAGDISH MANOHAR MANTRI, POONAM PRAKASH RATHI
- 14 Nov 20243 of 3 present2 independent
Stakeholders Relationship Committee
Chair RAKESH RAMSWAROOP SOMANI
JAGDISH MANOHAR MANTRI, POONAM PRAKASH RATHI
- 14 Nov 20243 of 3 present2 independent
- 14 Aug 20243 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- SPD AND ASSOCIATESPeer-review certificate valid to Nov 2026
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Skybiotech Healthcare AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.
Annual general meeting, 30 Sep 2026
649 shareholders on the register on 23 Sep 2026; present: 4 promoters and 3 others; votes counted by SEEMA MUNJAJI DHUMAL / SM DHUMAL & ASSOCIATES.The company's voting result
- To consider, approve and adopt Audited Financial Statements (Standalone), Reports of the Board and Auditor for the year ended 31st March, 2026Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.11%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 1.18%
- To consider, approve and adopt Audited Financial Statements (Consolidated) and Auditor for the year ended 31st March, 2026Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.11%
Turnout: all 63.91% · promoters 100.00% · other public 1.18%
- Re-appointment of Mr. Prakashchandra Rathi (DIN: 01393087), who retires by rotation as a director and being eligible, offers himself for re-appointmentOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · other public 0.11%
Turnout: all 5.74% · promoters 8.36% · other public 1.18%
- To consider and approve the appointment of M/s. SPD & Associates, Chartered Accountant (FRN: 139118W), as statutory Auditor of Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.11%
Turnout: all 63.91% · promoters 100.00% · other public 1.18%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Compliance
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
The company's own answers in its filing.